This trial will help build programs to refer people who use drugs to harm reduction services, including syringe services, naloxone overdose prevention, and referral for substance use treatment.
1 Primary · 14 Secondary · Reporting Duration: 2 years
600 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age Any Age · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: